AVTX EPS Estimates
Avalo Therapeutics, Inc.
$11.84
-$0.17(-1.42%)
32
Overall
60
Value
9
Tech
28
Quality
Market Cap
$644.10M
Volume
1.24M
52W Range
$12.51 - $24.27
Target Price
$44.08
AVTX EPS estimates: the consensus estimate for Avalo Therapeutics, Inc.'s current fiscal year is -$2.80 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AVTX EPS Estimates
- EPS estimate, current quarter
- $-0.63
- EPS estimate, next quarter
- $-0.65
- EPS estimate, current year
- $-2.80
- EPS estimate, next year
- $-2.87
- EPS growth, 3-year
- +82.36%
| Fiscal year | EPS |
|---|---|
| 2025 | $-5.84 |
| 2024 | $-7.94 |
| 2023 | $-114.00 |
| 2022 | $-1063.20 |
| 2021 | $-14342.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $11.84 | -1.4% | 1.24M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Avalo Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW